Blade Q1 revenue $54.3M (+5.4% YoY); net loss improves to $(3.5)M; reaffirms FY2025 positive Adj. EBITDA

Strata Critical Medical, Inc.

2025-Q1 EPS reported -$0.04 revenue$54,306,000

Revenue $54.3M (+5.4% YoY); excluding exited Canada, up 10.9%.
Net loss $(3.5)M, improved $0.7M YoY; Adj. EBITDA $(1.2)M, improved $2.3M YoY.
Passenger segment Adj. EBITDA $0.1M, first profitable Q1 since IPO (+$2.7M YoY).
Medical segment Adj. EBITDA $4.1M; new monthly trip volume record set in April 2025.
Reaffirms guidance: double-digit millions of Adjusted EBITDA for full-year 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.